ArticlePloS one2014

DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations.

Koichiro Nozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.